RxDoctor Payments DataLook up a doctor →

Anuradha Reddy, MD

Rheumatology · Baltimore, MDNPI 1760559009

Payments from drug & device makers

$20,130in general payments, 2019–2025

Across 705 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$4K
  • Amgen$4K
  • Pfizer$1K
  • AstraZeneca$1K
  • AbbVie$1K
  • GSK$959
  • plus $8K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mallinckrodt Hospital Products Inc.85$3,742
Amgen(2 entities)61$3,569
Pfizer76$1,391
AstraZeneca(2 entities)47$1,282
AbbVie(2 entities)51$1,169
GSK46$959
Kowa Pharmaceuticals America, Inc.36$860
Johnson & Johnson(2 entities)31$855
Bayer38$779
Lilly USA, LLC37$726
Astellas Pharma US Inc25$557
Novo Nordisk27$546
Sumitomo Pharma America, Inc.24$518
Novartis18$462
ANI Pharmaceuticals, Inc.13$373
Mallinckrodt Enterprises LLC8$295
Xeris Pharmaceuticals, Inc.11$295
Sanofi-aventis U.S. LLC4$252
E.r. Squibb & Sons, L.L.C.10$193
Merck12$184
Regeneron Healthcare Solutions, Inc.7$131
Amarin Pharma, Inc.1$117
Urovant Sciences Inc1$110
Biogen4$102
Biohaven Pharmaceutical Holding Company Ltd.3$81
Hikma Pharmaceuticals USA5$79
Boehringer Ingelheim3$62
Radius Health, Inc.2$51
Global Blood Therapeutics, Inc.2$50
UCB, Inc.2$50
Orexo US, Inc.2$49
Sanofi3$43
Bristol Myers Squibb2$38
Sunovion Pharmaceuticals Inc.2$32
Exact Sciences1$23
Medicure Pharma Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$21
Ultragenyx Pharmaceutical Inc.1$21
Sobi, Inc1$20
Neurocrine Biosciences, Inc.1$19

How this compares

$20,130 in reported general payments places this provider in the 70th percentile of 173 rheumatology providers in Maryland.

See all rheumatology providers in Maryland →

Medicare billing

Part B allowed, 2024
$135,893
Medicare patients
105
Services billed
1,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →